These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26679400)

  • 1. Oral tacrolimus for the treatment of generalized morphea.
    Hirohata A; Hanafusa T; Igawa K; Inoue-Nishimoto T; Mabuchi-Kiyohara E; Nishide M; Yokozeki H; Ikegami R
    Eur J Dermatol; 2016; 26(1):112-3. PubMed ID: 26679400
    [No Abstract]   [Full Text] [Related]  

  • 2. Generalized morphea successfully treated with tacrolimus 0.1% ointment.
    Cantisani C; Miraglia E; Richetta AG; Mattozzi C; Calvieri S
    J Drugs Dermatol; 2013 Jan; 12(1):14-5. PubMed ID: 23377321
    [No Abstract]   [Full Text] [Related]  

  • 3. A patient with plaque type morphea mimicking systemic lupus erythematosus.
    Wardhana ; Datau EA
    Acta Med Indones; 2015 Apr; 47(2):146-52. PubMed ID: 26260557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.
    Kroft EB; Groeneveld TJ; Seyger MM; de Jong EM
    Am J Clin Dermatol; 2009; 10(3):181-7. PubMed ID: 19354332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study.
    Stefanaki C; Stefanaki K; Kontochristopoulos G; Antoniou C; Stratigos A; Nicolaidou E; Gregoriou S; Katsambas A
    J Dermatol; 2008 Nov; 35(11):712-8. PubMed ID: 19120765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generalized scleroderma. Treatment with immunosuppressive agents].
    Saporta L; Godeau P; Delrieu F; Delbarre F
    Nouv Presse Med; 1972 Jul; 1(29):1929-30. PubMed ID: 5053601
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab: a potential therapeutic advance in scleroderma: what is the evidence?
    Simms RW; Lafyatis R
    Rheumatology (Oxford); 2010 Feb; 49(2):201-2. PubMed ID: 20032221
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of scleroderma].
    Guillevin L; Ortonne JP
    Ann Med Interne (Paris); 1983; 134(8):754-65. PubMed ID: 6364917
    [No Abstract]   [Full Text] [Related]  

  • 9. What can we learn from negative clinical trials in systemic sclerosis?
    Veale DJ
    Clin Exp Rheumatol; 2010; 28(2 Suppl 58):S1-4. PubMed ID: 20576207
    [No Abstract]   [Full Text] [Related]  

  • 10. New treatments in scleroderma: the rheumatologic perspective.
    Righi A; Cerinic MM
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):431-2. PubMed ID: 12428830
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclophosphamide for scleroderma lung disease.
    Martinez FJ; McCune WJ
    N Engl J Med; 2006 Jun; 354(25):2707-9. PubMed ID: 16790705
    [No Abstract]   [Full Text] [Related]  

  • 12. Poor efficacy of oral tacrolimus in the treatment of severe generalized atopic eczema in adults: a small retrospective case series.
    Lee FJ; Frankum BS; Katelaris CH
    Australas J Dermatol; 2012 Nov; 53(4):295-7. PubMed ID: 23157781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus--finally!
    Herrlinger KR; Fellermann K; Stange EF
    Gut; 2006 Sep; 55(9):1224-5. PubMed ID: 16905691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized scleroderma: response to occlusive treatment with tacrolimus ointment.
    Mancuso G; Berdondini RM
    Br J Dermatol; 2005 Jan; 152(1):180-2. PubMed ID: 15656828
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous HSCT in systemic sclerosis: a step forward.
    Farge D; Gluckman E
    Lancet; 2011 Aug; 378(9790):460-2. PubMed ID: 21777973
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized pustular psoriasis successfully treated with topical tacrolimus.
    Rodríguez García F; Fagundo González E; Cabrera-Paz R; Rodriguez Martín M; Sáez Rodríguez M; Martín-Neda F; García Bustinduy M; Noda Cabrera A; Sánchez González R
    Br J Dermatol; 2005 Mar; 152(3):587-8. PubMed ID: 15787845
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ulcerated necrobiosis lipoidica: successful treatment with topical tacrolimus and hydroxychloroquine].
    Mirkamali A; Carbonnelle-Puscian A; Bagot M
    Ann Dermatol Venereol; 2010; 137(8-9):561-2. PubMed ID: 20804904
    [No Abstract]   [Full Text] [Related]  

  • 18. Connective tissue diseases: Immunosuppressive therapy in SSc: what is the target?
    Boin F; Wigley F
    Nat Rev Rheumatol; 2009 Jul; 5(7):357-8. PubMed ID: 19568247
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclophosphamide versus placebo in scleroderma lung disease.
    Tashkin DP; Elashoff R; Clements PJ; Goldin J; Roth MD; Furst DE; Arriola E; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M;
    N Engl J Med; 2006 Jun; 354(25):2655-66. PubMed ID: 16790698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma treated with immunosuppressive drugs.
    Kurwa AR; Denman AM
    Br J Dermatol; 1979 Jul; 101 Suppl 17():56-7. PubMed ID: 313805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.